Mr. Mark Upsdell reports

RAPID DOSE THERAPEUTICS ANNOUNCES A NEW BOARD MEMBER

Rapid Dose Therapeutics Corp. has appointed Angela O'Leary to the board of directors.

Mark Upsdell, CEO of RDT said: "We are excited to welcome Angela to our Board of Directors. She brings expertise, experience and leadership in government procurement and commercial revenue generation. Angela's proven success incubating and growing product sale revenues in the health sector align with the vision and critical success factors for RDT. We look forward to Angela sharing her own experiences and developed methodologies as we grow RDT revenues."

Angela O'Leary is a distinguished leader in the Canadian business landscape, renowned for her entrepreneurial skill and strategic leadership. Her career is highlighted by the successful establishment and growth of several enterprises, which have significantly impacted various sectors and generated substantial revenues. She holds the professional CBAP designation (certified business analysis professional), accredited by the IIBA, and she is also a Prosci-certified change management practitioner. She graduated from the University of Ottawa with a BA in Women's Studies.

A defining highlight of Angela O'Leary's career is her ownership and leadership role as CEO of a medical supply company. Under her stewardship, the company achieved remarkable success, particularly in the healthcare sector, with sales reaching into the hundreds of millions. This significant achievement demonstrates O'Leary's exceptional ability to propel growth and ensure profitability in highly competitive markets.

Her business journey includes founding and leading a staffing and sourcing firm, which was successfully acquired in a private deal, and holding a significant leadership role at a technology company. These roles further highlight her extensive experience and adeptness in business management.

O'Leary's ascent to CEO positions in multiple companies underscores her visionary leadership and strategic thinking. Her commitment to hard work and excellence has been a constant throughout her career.

In addition to her business achievements, O'Leary is deeply committed to philanthropy and societal betterment in Canada. She is a strong advocate for social responsibility, actively engaged in initiatives aimed at dismantling systemic barriers and inequalities across different facets of society, all with the overarching aim of making a significant and positive contribution to Canadian society. Her dedication to these causes is integral to her professional identity and philosophy.

About Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The Company's flagship product QuickStripTM is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. For more information about the Company, visit www.rapid- dose.com.

We seek Safe Harbor.